Azilsartan medoxomil is an adversary of angiotensin II receptors abstinent for the analysis of balmy accustomed capital hypertension. Edarbi is acclimated to amusement top claret burden (hypertension). It is sometimes accustomed with added medications.Azilsartan medoxomil claret burden a prodrug of Azilsartan as "Edarbi" Takeda is marketed.
Conversion of angiotensin I by angiotensin converting agitator (ACE) Angiotensin II the adrenal case angry to amalgamate aldosterone and secrete, decreased sodium elimination and added elimination of potassium, and acts as a vasoconstrictor vascular bland muscle.Azilsartan medoxomil has been shown, olmesartan and valsartan beat abate claret pressure.
No comments:
Post a Comment